Menu Close

Study Estimates Potential for Ranibizumab to Prevent Blindness from Age-Related Macular Degeneration

A computer modeling study suggests that administering the drug ranibizumab is associated with reducing the magnitude of legal blindness and visual impairment caused by age-related macular degeneration in non-Hispanic white individuals, according to a report in the June issue of Archives of Ophthalmology, one of the JAMA/Archives journals.